251 related articles for article (PubMed ID: 7537919)
1. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
Pengo V; Biasiolo A; Fior MG
Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
[TBL] [Abstract][Full Text] [Related]
2. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
4. Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome.
Wang MX; Kandiah DA; Ichikawa K; Khamashta M; Hughes G; Koike T; Roubey R; Krilis SA
J Immunol; 1995 Aug; 155(3):1629-36. PubMed ID: 7543528
[TBL] [Abstract][Full Text] [Related]
5. Reactivity to beta 2 glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis.
Forastiero RR; Martinuzzo ME; Kordich LC; Carreras LO
Thromb Haemost; 1996 May; 75(5):717-20. PubMed ID: 8725711
[TBL] [Abstract][Full Text] [Related]
6. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation.
Arvieux J; Darnige L; Hachulla E; Roussel B; Bensa JC; Colomb MG
Thromb Haemost; 1996 May; 75(5):725-30. PubMed ID: 8725713
[TBL] [Abstract][Full Text] [Related]
7. Phospholipid-independent binding of beta 2glycoprotein I by IgA from patients with antiphospholipid syndrome.
Galazka MW; Keil LB; Kohles J; Petersheim M; DeBari VA
Ann Clin Lab Sci; 1998; 28(3):153-9. PubMed ID: 9646856
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
Pengo V; Biasiolo A; Brocco T; Tonetto S; Ruffatti A
Thromb Haemost; 1996 May; 75(5):721-4. PubMed ID: 8725712
[TBL] [Abstract][Full Text] [Related]
9. [Antiphospholipid and anti beta 2-glycoprotein I antibodies].
Arvieux J; Roussel B; Colomb MG
Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939
[TBL] [Abstract][Full Text] [Related]
10. "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding.
Roubey RA; Eisenberg RA; Harper MF; Winfield JB
J Immunol; 1995 Jan; 154(2):954-60. PubMed ID: 7814895
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
12. Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding.
Wagenknecht DR; McIntyre JA
Thromb Haemost; 1993 Apr; 69(4):361-5. PubMed ID: 7684533
[TBL] [Abstract][Full Text] [Related]
13. Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid.
Keeling DM; Wilson AJ; Mackie IJ; Machin SJ; Isenberg DA
Br J Haematol; 1992 Nov; 82(3):571-4. PubMed ID: 1486037
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies: new perspectives on antigenic specificity.
Jones JV
J Rheumatol; 1992 Nov; 19(11):1774-7. PubMed ID: 1283412
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
17. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
[TBL] [Abstract][Full Text] [Related]
18. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
[TBL] [Abstract][Full Text] [Related]
19. Specificities and characteristics of beta 2 glycoprotein I-induced antiphospholipid antibodies.
Gharavi AE; Sammaritano LR; Bovastro JL; Wilson WA
J Lab Clin Med; 1995 Jun; 125(6):775-8. PubMed ID: 7769372
[TBL] [Abstract][Full Text] [Related]
20. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.
Roubey RA; Pratt CW; Buyon JP; Winfield JB
J Clin Invest; 1992 Sep; 90(3):1100-4. PubMed ID: 1522218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
